IFx-2.0, an investigational cancer immunotherapy, is advancing in Phase III trials targeting Merkel cell carcinoma and other skin cancers resistant to checkpoint inhibitors like pembrolizumab. Early trials showed a 63% response rate in refractory patients, with durable effects lasting up to nearly three years. The therapy's orphan drug designation and combination potential with KEYTRUDA may accelerate adoption and commercial success in major markets including the US, EU, UK, and Japan. Market forecasts through 2034 highlight IFx-2.0's promising role in addressing unmet needs in cancer treatment resistant to current immunotherapies.
The IFx 2.0 cancer immunotherapy market outlook is presented here with Pluang's Health sector data as context. As of Oct 13, 2026 16:11 WIB, 76 of 128 priced US Health-sector stocks rose while 45 fell. Notable movers include AZN at USD 162.60 with a 2.70% increase, SNY at USD 40.52 up 1.96%, and UNH at USD 385.31 rising 1.79%.
Foresight Autonomous Holdings has signed a non-binding term sheet to acquire a 50.01% controlling interest in a company developing two data center projects in Warsaw and Wroclaw, Poland, with a combined planned capacity of 270 MW. This move aligns wi...
YieldMax ETFs declared weekly distributions for their Group 1 ETFs, with payment on October 15, 2026. The distributions vary by ETF, reflecting different distribution rates and 30-day SEC yields, ranging from about 23% to over 60%. These ETFs cover s...
The Asia-Pacific sustainable data center market is projected to grow from $16.74 billion in 2025 to $57.18 billion by 2031, at a CAGR of 22.7%. Growth is fueled by rising demand for AI, cloud computing, and hyperscale infrastructure, prompting invest...
Holafly has introduced the Ultra Plan, a new global eSIM subscription that offers unlimited mobile data alongside health and wellness services, including 24/7 medical messaging, mental health sessions, nutrition and fitness coaching, and veterinary a...
TeraWulf has transitioned from bitcoin mining to leasing AI data centers, securing over $27 billion in long-term contracted revenue across 839MW of critical IT loads. Key leases include a 20-year, 401MW agreement with Anthropic and several deals back...
